Sickle Cell and AVN Treatment

 

After living with sickle cell disease and facing severe joint damage (avascular necrosis), Kambeyo was told she would need four major joint replacement surgeries. Seeking a non-surgical solution, she traveled to StemRx in India for a 30-day treatment plan combining stem cell therapy and targeted epigenetic modulation. Today, Kambeyo has avoided major surgery, regained her mobility, and reclaimed her independent, daily life.